Cargando…

Comparisons of metastatic patterns of colorectal cancer among patients by age group: a population-based study

Population-based evaluations of the incidence of metastatic colorectal cancer at diagnosis among different age groups are lacking. Therefore, we investigated the effects of age at diagnosis on metastatic colorectal cancer and patients’ prognoses. The Surveillance, Epidemiology, and End Results datab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Lin, Yang, Xingli, He, Wenzhuo, Liu, Shousheng, Jiang, Chang, Xie, Kunqian, Peng, Kunwei, You, Yafei, Zhang, Bei, Xia, Liangping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326680/ https://www.ncbi.nlm.nih.gov/pubmed/30594909 http://dx.doi.org/10.18632/aging.101700

Ejemplares similares

Proximal shift of colorectal cancer with increasing age in different ethnicities
por: Yang, Lin, et al.
Publicado: (2018)

The Prognostic and Predictive Value of Carbohydrate Antigen 19-9 in Metastatic Colorectal Cancer Patients with First Line Bevacizumab Containing Chemotherapy
por: Jiang, Chang, et al.
Publicado: (2017)

Previous Use of Anti-Vascular Endothelial Growth Factor Receptor Agents Decreases Efficacy of Fruquintinib in Metastatic Colorectal Cancer Refractory to Standard Therapies
por: Wang, Lei, et al.
Publicado: (2020)

Longterm effects of palliative local treatment of incurable metastatic lesions in colorectal cancer patients
por: Yang, Qiong, et al.
Publicado: (2016)

Brain metastases in newly diagnosed colorectal cancer: a population-based study
por: Yang, Lin, et al.
Publicado: (2018)

First-line cetuximab improves the efficacy of subsequent bevacizumab for RAS wild-type left-sided metastatic colorectal cancer: an observational retrospective study
por: Liu, Shousheng, et al.
Publicado: (2020)

Characterisation of tumor microenvironment and prevalence of CD274/PD-L1 genetic alterations difference in colorectal Cancer
por: Yang, Lin, et al.
Publicado: (2023)

Second primary colorectal cancer after the initial primary colorectal cancer
por: Yang, Lin, et al.
Publicado: (2018)

Metastatic lymph node ratio as a prognostic indicator in patients with stage IV colon cancer undergoing resection
por: Jiang, Chang, et al.
Publicado: (2019)

Optimal Surgery Type and Adjuvant Therapy for T1N0M0 Lung Large Cell Neuroendocrine Carcinoma
por: Peng, Kunwei, et al.
Publicado: (2021)

Tumor microenvironment classification based on T-cell infiltration and PD-L1 in patients with mismatch repair-proficient and -deficient colorectal cancer
por: Liu, Shousheng, et al.
Publicado: (2019)

Circulating Lymphocytes, PD-L1 Expression on Tumor-infiltrating Lymphocytes, and Survival of Colorectal Cancer Patients with Different Mismatch Repair Gene Status
por: Kong, Pengfei, et al.
Publicado: (2019)

The Efficacy of Bevacizumab in Different Line Chemotherapy for Chinese Patients with Metastatic Colorectal Cancer
por: Yin, Chenxi, et al.
Publicado: (2016)

Bevacizumab plus chemotherapy as third- or later-line therapy in patients with heavily treated metastatic colorectal cancer
por: Yang, Qiong, et al.
Publicado: (2015)

Predictive value of prognostic nutritional and systemic immune-inflammation indices for patients with microsatellite instability-high metastatic colorectal cancer receiving immunotherapy
por: Yi, Jiahong, et al.
Publicado: (2023)

Prognostic value of total number of lymph nodes retrieved differs between left-sided colon cancer and right-sided colon cancer in stage III patients with colon cancer
por: Yang, Lin, et al.
Publicado: (2018)

Metformin selectively inhibits metastatic colorectal cancer with the KRAS mutation by intracellular accumulation through silencing MATE1
por: Xie, Jinye, et al.
Publicado: (2020)

Positive impact of the negative lymph node count on the survival rate of stage III colon cancer with pN1 and right-side disease
por: Quan, Qi, et al.
Publicado: (2019)

Initial LDH level can predict the survival benefit from bevacizumab in the first-line setting in Chinese patients with metastatic colorectal cancer
por: Yin, Chenxi, et al.
Publicado: (2014)

A high LDL-C to HDL-C ratio predicts poor prognosis for initially metastatic colorectal cancer patients with elevations in LDL-C
por: Liao, Fangxin, et al.
Publicado: (2015)

Efficacy and mechanism of combination of oxaliplatin with PKM2 knockdown in colorectal cancer
por: Yin, Chenxi, et al.
Publicado: (2020)

Safety and Efficacy of Long-Term Zoledronic Acid in Advanced Breast Cancer with Bone Metastasis in South China
por: Wang, Qianyu, et al.
Publicado: (2020)

Comparison of patterns and prognosis among distant metastatic breast cancer patients by age groups: a SEER population-based analysis
por: Chen, Meng-Ting, et al.
Publicado: (2017)

Prognostic value of inflammation-based scores in patients receiving radical resection for colorectal cancer
por: Wang, Fang, et al.
Publicado: (2018)

Immune Cell Infiltration of the Primary Tumor Microenvironment Predicted the Treatment Outcome of Chemotherapy With or Without Bevacizumab in Metastatic Colorectal Cancer Patients
por: Wang, Yixing, et al.
Publicado: (2021)

Effect of HK2, PKM2 and LDHA on Cetuximab efficacy in metastatic colorectal cancer
por: Wang, Haohua, et al.
Publicado: (2018)

Impact of Serum Apolipoprotein A-I on Prognosis and Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer: a Propensity Score-Matched Analysis()
por: Quan, Qi, et al.
Publicado: (2017)

Establishment of inflammation biomarkers-based nomograms to predict prognosis of advanced colorectal cancer patients based on real world data
por: Guo, Guifang, et al.
Publicado: (2018)

Treatment patterns for metastatic colorectal cancer in Spain
por: Aranda, E., et al.
Publicado: (2020)

Central Compartment Lymph Nodes Have Distinct Metastatic Patterns in Different Age Groups
por: Yan, Caigu, et al.
Publicado: (2022)

Adipose tissue area as a predictor for the efficacy of apatinib in platinum-resistant ovarian cancer: an exploratory imaging biomarker analysis of the AEROC trial
por: Huang, Xin, et al.
Publicado: (2020)

A large-cohort retrospective study of metastatic patterns and prognostic outcomes between inflammatory and non-inflammatory breast cancer
por: Wang, Zheng, et al.
Publicado: (2020)

Comparison of wild rice (Oryza longistaminata) tissues identifies rhizome-specific bacterial and archaeal endophytic microbiomes communities and network structures
por: Peng, Xiaojue, et al.
Publicado: (2021)

Tumor-infiltrating lymphocyte as a prognostic biomarker in stage IV colorectal cancer should take into account the metastatic status and operation modality
por: Xie, Qian-Kun, et al.
Publicado: (2018)

Association between Mismatch-repair Genetic variation and the Risk of Multiple Primary Cancers: A Meta-Analysis
por: Kong, Pengfei, et al.
Publicado: (2017)

Immune cell concentrations among the primary tumor microenvironment in colorectal cancer patients predicted by clinicopathologic characteristics and blood indexes
por: Guo, Guifang, et al.
Publicado: (2019)

Rechallenge of oxaliplatin-containing regimens in the third- or later-line therapy for patients with heavily treated metastatic colorectal cancer
por: Yang, Qiong, et al.
Publicado: (2018)

Primary Tumor Location as a Predictive Factor for First-line Bevacizumab Effectiveness in Metastatic Colorectal Cancer Patients
por: He, Wen-Zhuo, et al.
Publicado: (2017)

Efficacy and safety of third-line or later-line targeted treatment for patients with metastatic colorectal cancer: a meta-analysis
por: Xue, Wen-Hui, et al.
Publicado: (2023)

Comparison of immunological characteristics between paired mismatch repair-proficient and -deficient colorectal cancer patients
por: Liu, Shou-Sheng, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fcuiuece8gigng6stg80t2h7nl